Luxembourg - Beta Blocking Medicine Use
Since 2014, Luxembourg Beta Blocking Medicine Use decreased by 0.6% year on year. In 2019, the country was number 15 comparing other countries in Beta Blocking Medicine Use with 38.5 Units (Defined Daily Dosage) Per Thousand Persons Per Day. Luxembourg is overtaken by Netherlands, which was number 14 with 45.2 Units (Defined Daily Dosage) Per Thousand Persons Per Day and is followed by Portugal at 38.1 Units (Defined Daily Dosage) Per Thousand Persons Per Day. Germany lead the ranking with 81.9 Units (Defined Daily Dosage) Per Thousand Persons Per Day in 2019, an increase of 2.1% versus 2018. Lithuania, Belgium and Hungary respectively ranked number 2, 3 and 4 in this ranking. Turkey witnessed the best average annual growth at +5% per year, while Chile recorded the worst performance at -4.9% per year.
| Date | Units (Defined Daily Dosage) Per Thousand Persons Per Day |
|---|---|
| 2019 | 38.50 |
| 2018 | 39.20 |
| 2017 | 38.70 |
| 2016 | 39.30 |
| 2015 | 39.40 |
How does Luxembourg rank in Beta Blocking Medicine Use?
| # | 28 Countries | Units (Defined Daily Dosage) Per Thousand Persons Per Day | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
Germany
|
82 | 2019 | +2.1 % | -1.6 % | View data | |
| 2 |
#2
Lithuania
|
77 | 2019 | +3.4 % | +1.6 % | View data | |
| 14 |
#14
Netherlands
|
45 | 2019 | +0.4 % | -2.1 % | View data | |
| 15 |
#15
Luxembourg
|
39 | 2019 | -1.8 % | -0.6 % | View data | |
| 16 |
#16
Portugal
|
38 | 2019 | +5.0 % | +2.7 % | View data | |